Zofran is used for preventing nausea and vomiting associated with cancer chemotherapy or surgery.
GO TO STORE >>
Zofran is used for preventing nausea and vomiting associated with cancer chemotherapy or surgery.
Active Ingredient: Ondansetron
Zofran (Cetron) as known as: Amal, Amilene, Ansentron, Antivom, Atossa, Avessa, Axisetron, Biosetron, Cedantron, Cellondan, Cetron, Cruzafen, Danac, Dantenk, Dantron 8, Dantroxal, Dentron, Dismolan, Ebesetron, Emeset, Emetron, Emistat, Emital, Emizof, Entron, Espasevit, Fedral, Finaber, Frazon, Gardoton, Invomit, Izofran, Kliran, Lametic, Lartron, Modifical, Modificial, Nafroz, Nalisen, Nausedron, Nofail, Noventron, Odanex, Odanostin, Odasen, Odnatron, Onaserone, Oncodex, Oncoemet, Onda, Ondagen, Ondameton, Ondansan, Ondansetrona, Ondansetronum, Ondaren, Ondaron, Ondasan, Ondaseprol, Ondavell, Ondemet, Ondeton, Ondomet, Ondran, Onetic 4, Onfran, Onilat, Onsat, Onsetrogen, Onsetron, Onsia, Osetron, Otredil, Seton, Setronon, Sigondan, Tiosalis, Trorix, Trosedan, Trovensis, Vomceran, Vometraz, Vometron, Vomino, Vomiof, Vomiz, Yatrox, Zemitron, Zofer, Zofron, Zoltem, Zophren, Zotrix
Center for Disease Control and Prevention, National Center for Infectious Diseases, Division of Global Migration and Quarantine, 1600 Clifton Road, Atlanta, GA 30333, USA
Yale J Biol Med 78:329-34. 2005
Division of Global Migration and Quarantine, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
Emerg Infect Dis 10:2053-4. 2004
Center for Disease Control and Prevention, National Center for Infectious Diseases, Division of Global Migration and Quarantine, 1600 Clifton Road, Atlanta, GA 30333, USA
Yale J Biol Med 78:329-34. 2005
Division of Global Migration and Quarantine, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
Emerg Infect Dis 10:2053-4. 2004
Labome.Org © 2015 All Rights Researved
Princeton, New Jersey 08540, USA
With Your Account From "Bionika Media" ' data-placement='bottom' target='_self'>LoginImported rickettsial diseases detected in Moscow among tourists from endemic foci
Tarasevich I.V. Saifullin M.A. Luchshev A.V. Pantyukhina A.N. Mazankova L.N. Dudina K.R. Makarova V.A. Shpynov S.N.
1N.F Gamaleya Federal Research Center for Epidemiology and Microbiology, Ministry of Health of Russia, Moscow; 2Infectious Diseases Hospital One, Moscow Healthcare Department; 3Branch One, A.A. Vishnevsky Central Military Clinical Hospital Three, Ministry of Defense of Russia, Moscow; 4Russian Medical Academy of Postgraduate Education, Ministry of Health of Russia, Moscow 5A.I. Evdokimov Moscow State University of Medicine and Dentistry
The paper gives data on the epidemiology, clinical course, and diagnosis of imported rickettsial diseases detected in Moscow among the tourists returning from the endemic regions.Subscribe Literature About the Autors
Prof. Tarasevich Irina Vladimirovna, BD; Acad. of the Russian Academy of Medical Sciences, Head, Laboratory of Rickettsial Environment, N.F. Gamaleya Research Institute of Epidemiology and Microbiology, Ministry of Health of Russia
Address: 18, Gamaleya St. Moscow 123098
Telephone: +7(499) 193-61-85
Professor Chris Baggoley is Chief Medical Officer of the Australian Government Department of Health, Ministry of Health of Australia. He is also the principal medical adviser to the Minister and the Australian Government Department of Health and holds direct responsibility for the Department's Office of Health Protection.
Previously, Professor Baggoley, whose clinical background is in emergency medicine, was Chief Executive of the Australian Commission on Safety and Quality in Health Care and Chief Medical Officer and Executive Director with the South Australian Department of Health. He was also President of the Australasian College for Emergency Medicine, Chair of the National Committee of Presidents of Medical Colleges and Chair of the Board of the National Institute of Clinical Studies.
Professor Baggoley chairs a number of national committees, including the Australian Health Protection Principal Committee, the Australian Therapeutic Goods Advisory Council and the National Cancer Expert Reference Group. Other current professional activities include membership of several Antimicrobial Resistance Committees, the National Health and Medical Research Council and the Australian Animal Health Laboratory Strategic Policy Group.
He represents Australia on the International Agency for Research on Cancer Governing Council.Vice-Chair Dr Theresa Tam, Branch Head, Health Security Infrastructure Branch, Public Health Agency of Canada, Ottawa, Canada
Dr Theresa Tam is currently the head of the Health Security Infrastructure Branch of the Public Health Agency of Canada (PHAC). She is responsible for leading on key initiatives and programmes on health emergency management, border health security, implementation of the International Health Regulations (IHR) for Canada, development of public health system capacity development, facilitation of action on public health surveillance priorities and the health response for international mass gathering events.
Dr Tam is the former Director General, Centre for Emergency Preparedness and Response, and the former Director, Immunization and Respiratory Infections Division, both at PHAC. She was the Federal co-chair of the Pandemic Influenza Committee of Canada and co-chair of the Canadian Immunization Committee.
Her professional concentration include paediatrics, infectious diseases, field epidemiology with extensive experience in the management of complex health emergency situations including the SARS outbreak, the outbreak of avian influenza in British Columbia, Canada, and the 2009 H1N1 influenza pandemic.Rapporteur Dr Salah Al Awaidy, Communicable Diseases Adviser to Health Affairs, Ministry of Health, Muscat, Oman
Dr Salah Al Awaidy is Communicable Diseases Adviser to Health Affairs of the Oman Ministry of Health. From 1997-2011, he was Director of Communicable Disease Surveillance and Control at the Ministry of Health.
His primary fields of professional concentration include vaccination and vaccinology, vaccine cold chain, communicable diseases surveillance, eradication and elimination, as well as the implementation of the International Health Regulations (2005).
He has actively participated in a number of international meetings and forums organized by WHO. Since 2005, he has been responsible for a WHO Collaborating Centre team that carries out global and regional training on vaccine and central store management.Members Professor Tjandra Aditama, Director General, Disease Control and Environmental Health, Ministry of Health, Jakarta, Indonesia
Professor Tjandra Aditama is Director General of the Department of Disease Control and Environmental Health, Ministry of Health in Indonesia. His previous employment includes Director of Communicable Disease Control, Ministry of Health, and senior and director level positions at the Persahabatan Hospital in Jakarta.
He serves as a member of the International Union against Tuberculosis and Lung Diseases, the Research Institute of Tuberculosis, Tokyo, Japan, the Asia Pacific Society of Respirology, the executive body of the International Coalition against Tobacco, and the Network of Islamic Approach against Tobacco.Dr Abdullah Al-Assiri, Assistant Deputy Minister of Health for Preventive Health, Riyadh, Kingdom of Saudi Arabia
Dr Abdullah M Assiri is the Assistant Deputy Minister for Preventive Health in the Kingdom of Saudi Arabia. He is also a consultant in internal medicine and infectious disease at the King Fahad Medical City in Riyadh.
Previous positions held by Dr Assiri include Director-General for Infection Prevention and Control at the Ministry of Health and Advisor to the Deputy Minister of Public Health. He was also a consultant in internal medicine and infectious disease for the armed forces and the national guard. Dr Assiri was formally a clinical fellow in the infectious diseases division at Dalhousie University in Halifax, Canada. He further worked as an Assistant Consultant to the Department of Medicine at King Faisal Specialist Hospital in Jeddah.
Other current professional activities and positions of Dr Assiri include Fellow of the American College of physicians, Adjunct Associate Professor of Hubert Department of Global Health at Emory University and a member of the Editorial Board of the Journal of Epidemiology and Global Health. Since 2010 he also chairs the National Infection Control Committee and is a member of the National Committees on AIDS, Immunization, tuberculosis, Decontamination Services and of the Scientific Committee for the International Conference on Mass Gatherings.
Dr Assiri is currently the representative of the Kingdom of Saudi Arabia to the Executive Board of the World Health Organization.Dr Hussain Al Rand, Assistant Undersecretary for Health Centers and Clinics, Abu Dhabi, United Arab Emirates
Dr Hussain Al Rand is the Assistant Undersecretary for Health Centres and Clinics at the Ministry of Health, Dubai, which includes the supervision of five departments: Primary Health Care, Preventive Medicine, Laboratories, Health Education and Promotion, supporting health services, including Nutrition and Occupational health and Radiology.
Previously, Dr Hussain was the Director of Medical Affairs, Consultant and Head of the ENT (Otorhinolaryngology) Department, Dubai Hospital, Dubai Health Authority, as well as Associate Professor and Head of ENT Section at the Dubai Medical College for Girls. Other positions held by Dr Al Rand include President of Pan-Arab Federation of ORL-HNS Societies, President of the ORL, Head and Neck Society, Gulf Cooperation Council, and President of the ORL, Head and Neck Society, United Arab Emirates.
Other current professional activities of Dr Al Rand include memberships in the German Academy of Otolaryngology Head and Neck Surgery Inc. the American Academy of Otolaryngology, Head and Neck Surgery Inc. and the Board Committee of the Gulf Cooperation Council of the Oto-Rhino-Laryngological Head and Neck Society.Dr Martin Cetron, Director, Division of Global Migration and Quarantine, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, United States of America
Dr Martin Cetron is the Director for the Division of Global Migration and Quarantine (DGMQ) at the United States Centers for Disease Control and Prevention (CDC).
His primary research interests are global health and migration with a focus on emerging infections, tropical diseases, and vaccine-preventable diseases in mobile populations. For over 20 years, Dr Cetron has conducted epidemiologic research globally, developed global health policy and led domestic and international outbreak investigations including high profile international emergency responses to emerging infectious disease outbreaks. He played a leadership role in CDC responses to the 2001 anthrax bio-terrorism incident, the 2003 SARS epidemic, the 2003 US monkeypox outbreak, the 2005 Hurricane Katrina/Rita response, the influenza A (H1N1) pandemic 2009, and the on-going outbreak of MERS-CoV.
Dr Cetron holds faculty appointments in the Division of Infectious Disease at the Emory University School of Medicine and the Department of Epidemiology at Rollins School of Public Health.
Professor Claudia Gonzalez is a psychologist and researcher at the Center of Epidemiology and Public Health Policy of the Universidad del Desarrollo in Santiago de Chile since 2011. At the Center she has conducted research on infectious diseases such as tuberculosis in prisons, risk factors for meningitis in the Chilean population and knowledge and attitudes about hantavirus.
In 2009, she was in charge of the executive secretariat of the Committee for the Control of Outbreaks and Health Emergencies, the body responsible for handling the influenza A (H1N1) pandemic 2009 in Chile. She was also head of the National IHR Focal Point and responsible for implementing the IHR in Chile.
Professor Gonzalez has attended a number of international meetings and forums on influenza and IHR, organized by WHO/PAHO She was also a member of the Review Committee on the Functioning of the International Health Regulations (2005) in relation to Pandemic (H1N1) 2009.Dr Paata Imnadze, Head of Scientific Board, National Center for Disease Control and Public Health, Tbilisi, Georgia
Dr Paata Imnadze is head of the Scientific Board at the National Center for Disease Control and Public Health in Georgia.
Prior to his current position, he was Director General of the National Center for Disease Control and Public Health. He continues to serve as the Head of the Department of Public Health at the Tbilisi State University, and was formerly Associate Professor of the Department of Microbiology and Immunology at the Tbilisi State Medical University.
His professional experience includes epidemiology of communicable diseases, biosafety, infection control, microbiology, molecular epidemiology, emergency preparedness and response.
Dr Imnadze is member of the National Council on Bioethics and Vice President of both the Biosafety Association of Central Asia and Caucasus as well as the Scientific Association of Infectious Diseases, Epidemiology and Microbiology of Georgia.Dr Fadzilah Kamaludin, Head, Office of Deputy Director General of Health (Public Health), and Director, Epidemic Intelligence Program (Field Epidemiology Training Program), Ministry of Health, Putrajaya, Malaysia
Dr Fadzilah Kamaludin is Director of the Epidemic Intelligence Programme and Head of the Office of Deputy Director of Health (Public Health) of Malaysia. In both her capacities, she is actively involved with training public health physicians and public health practitioners in infectious disease outbreaks, surveillance and rapid response.
Previously, Dr Kamaludin was Deputy Director Management &Training, Institute of Public Health (2008-2012) and Principal Assistance Director, Surveillance Section, Disease Control Division, Ministry of Health (2004-2008).
Her professional experience and interests are in field investigation and training in infectious diseases surveillance and response.
She was previously involved with WHO in a number of consultancies including the modified Field Epidemiology Training Programme (FETP), Field Epidemiology Training (FET) and applied epidemiology. She has also been a WHO temporary advisor in the development of guidelines for outbreak risk communication.
Dr Larsen has held a number of public health positions with a focus on management of the health sector, health economics, use of Information and Communications Technology (ICT) in health services, and preventive medicine. As Director General for Health, he has led the Norwegian work on pandemic influenza, the Norwegian health preparedness committee, the Norwegian priority council for health services and the patient safety initiative. As Secretary-General, he is currently heading national programs on e-health and health research.
In May 2013, he ended his three year membership on the Executive Board of the World Health Organization, having served one year as vice president. Dr Larsen has also chaired the Standing Committee for the Regional Committee for WHO Europe. Dr Larsen has been especially engaged in WHO reform, the non-communicable disease epidemic, and health systems development, including health workforce shortage.Dr Ziad Memish, Deputy Minister for Public Health, Riyadh, Kingdom of Saudi Arabia 1
Dr Ziad Memish is Deputy Minister for Public Health in the Kingdom of Saudi Arabia. He is also Director of the WHO Collaborating Centre for Mass Gatherings Medicine, a consultant in adult infectious diseases at King Fahad Medical City, and a professor in the College of Medicine, Alfaisal University & King Saud University in Riyadh.
He was formerly the Assistant Deputy Minister of Health for Preventive Medicine in the Ministry of Health. He also used to serve as the Chairman of the Department of Infection Prevention and Control as well as the Executive Director for Infection Prevention and Control at the King Abdulaziz Medical City.
His main professional focus is public health, mass gatherings and infection control and infectious diseases.
Dr Memish is engaged with WHO as a member of the Executive Board of WHO, the International Infection Control Informal Network at WHO, the Core WHO Hand Hygiene Guidelines Committee in Geneva and the WHO Pandemic Influenza Preparedness framework committee. He has been a member of the WHO Virtual Interdisciplinary Advisory Board for Mass Gatherings (since 2008), and, as of this year, a member of the Strategic and Technical Advisory Group for Tuberculosis (STAG-TB). On a regional level, he is a member of the WHO EMRO Research Advisory Group, the WHO EMRO Regional Expanded Program for Immunization Advisory Group and the WHO Regional Network on Infection Control.Professor Babacar Ndoye, Expert-consultant and trainer in hospital hygiene, infection control and patient safety, Dakar, Senegal
Professor Babacar Ndoye is an expert-consultant and trainer in hospital hygiene, infection control and patient safety in Senegal.
Professor Ndoye recently retired, having set-up and led one of the first African national programs on infection prevention and control. He is currently setting up a training programme on hygiene and infection control in Senegal.
Professor Ndoye has been engaged with WHO in a number of working groups, including the Global Infection Prevention and Control Network (GIPCN), the Steering Committee of Save Lives, and the WHO working group for elaborating guidance for the prevention of surgical site infections. In 2008, he served WHO AFRO as an informal consultant regarding infection prevention and control in Africa.Professor Mahmudur Rahman, Director, Institute of Epidemiology, Disease Control and Research and National Influenza Centre, Ministry of Health and Family Welfare, Dhaka, Bangladesh
Professor Mahmudur Rahman, is Director of the Institute of Epidemiology, Disease Control and Research and National Influenza Center, Ministry of Health and Family Welfare in Bangladesh.
Previously, he served as the Professor and Head of the Department of Epidemiology at the National Institute of Preventive and Social Medicine (NIPSOM) from 2002 to 2004, following six years as Associate Professor of Epidemiology in NIPSOM.
Professor Rahman devoted most of his academic career to the fields of epidemiology and public health. His past research has focused on disease surveillance, communicable, particularly infectious disease, and non-communicable disease epidemiology and public health policy issues. He also played a key facilitator role in establishing the National Influenza Center, Biosecurity Level 3 and Nipah laboratory and web-based disease surveillance in Bangladesh. He has been instrumental in establishing the 8th Global Disease Detection centre of the United States Centers for Disease Prevention and Control in Bangladesh.
He is currently serving as a member of the WHO Expert Review Committee on Polio Eradication, the WHO Scientific Advisory Committee on Visceral Leishmaniasis, the Executive Board of the International Association of National Public Health Institutes (IANPHI), the SEAR Certification Commission for Polio Eradication (SEARCCPE), and he is Editorial Board member of the SEARO Journal. In addition, Professor Rahman chaired and served on a number of panels covering different issues of epidemiology, disease surveillance and public health policies, ranging from avian and pandemic influenza surveillance to health and population program planning.
Professor Rahman was member of the Review Committee on the Functioning of the International Health Regulations (2005) in relation to Pandemic (H1N1) 2009.Professor Maha Talaat, Director, Infection Control Unit and Deputy Director, Disease Prevention, Global Disease Detection and Response Center, United States Naval Medical Research Unit, No.3, Cairo, Egypt
Professor Maha Talaat is Director of the Infection Control Unit and Deputy Director for Disease Prevention at the Global Disease Detection and Response Center in Egypt at the US Naval Medical Research Unit, No.3 (NAMRU-3) in Cairo, Egypt.
Previously, she was the Director of the Community Medicine Department at the Theodor Bilharz Research Institute, and a member of the core team of an International Schistosomiasis Research Project in Egypt.
Professor Talaat's professional focus includes technical support to the Ministries of Health to develop national infection control programs in Egypt and other countries in the Eastern Mediterranean region. She also served as a principal investigator to manage a network of countries establishing surveillance of severe acute respiratory illnesses (EMARIS) since 2007. Her work for EMARIS includes capacity building of Ministries of Health and the establishment of standardized methodologies for the testing of MERS-CoV and other respiratory pathogens.
Professor Talaat has engaged with WHO on many occasions. She has been a WHO temporary advisor in several consultancies including promotion of infection control, surveillance of communicable diseases, and prevention of viral hepatitis in Egypt. She was also a member of the WHO committee for selection of grants (2004-2006) and is a current member of the WHO Global Network on Infection Prevention and Control in Healthcare for Preparedness and Response to Communicable Disease Crises.
Prior to this, he was the regional virologist and laboratory coordinator for WHO AFRO.
His professional career focusses on disease surveillance and laboratory diagnosis of viral diseases.
Professor Tomori holds a number of professional affiliations, including the President of Nigeria Academy of Sciences, Chair of the Scientific Steering Committee, Meningitis Free World Initiative, Chair of the Nigeria Expert Review Committee on Polio Eradication and Routine Immunization, Chair of the Nigeria National Medical Laboratory Strategic Plan Implementation Committee, member of the International Steering Committee of the International Consortium on Anti-Virals, member of the Judging Panel, GlaxoSmithKline-Save the Children Fund Healthcare Innovation Award, and senior editor of the African Journal of Laboratory Medicine.Professor Maria Zambon, Director, Reference Microbiology Services, Public Health England, London, United Kingdom of Great Britain and Northern Ireland
Professor Zambon is the Director of Reference Microbiology, Public Health England. She is also a consultant medical virologist, the Head of the UK National Influenza Centre, the UK National Microbiology Focal Point and the UK lead for pandemic influenza vaccine studies.
Her professional experience includes clinical virology, vaccines and antivirals with a focus on respiratory viruses, influenza virology, SARS diagnostics, as well as laboratory sciences for pandemic influenza and other emerging respiratory infections.
She has engaged with WHO on a number of occasions since 1999, including in the field of influenza, vaccines, antivirals, pandemic planning, diagnostics, laboratory capabilities, serological studies and SARS. In addition, she has been a member of IHR Emergency Committee for Pandemic Influenza since 2009, Director of WHO laboratory training courses for influenza in association with the WHO collaborating Centre Mill Hill and WHO Europe since 2005, and Director of the WHO National Influenza Centre for the United Kingdom of Britain and Northern Ireland.Advisers Dr Anthony Evans, Chief, Aviation Medicine Section, International Civil Aviation Organization
Previously, Dr Evans was the Chief Medical Officer of the Civil Aviation Authority for the United Kingdom of Great Britain and Northern Ireland.
Other current professional activities of Dr Evans include memberships in the Faculty of Occupational Medicine of the United Kingdom, of the Society of Occupational Medicine and of the Royal Aeronautic Society. He is also a Fellow of the Aerospace Medical Association and Deputy Secretary General of the International Academy of Aviation and Space Medicine.
Dr Evans has been a consultant to the World Health Organization, a member of the International Health Regulations (IHR) Emergency Committee concerning Influenza Pandemic (H1N1) and is currently an adviser to the IHR Emergency Committees concerning Ebola and Poliomyelitis.Dr Bernard Faye, Consultant to the Food and Agriculture Organization of the United Nations, Camel project, Center for Agriculture Project, Al-Kharj, Kingdom of Saudi Arabia, and Senior Scientist, French Agricultural Research Centre for International Development, Montpellier, France
Dr Faye is currently a consultant to the Food and Agriculture Organization of the United Nations (FAO) on a camel project in the Kingdom of Saudi Arabia, and a Senior scientist and project manager in the animal production sector at the French Agricultural Research Centre for International Development (CIRAD), Montpellier, France. His area of professional concentration is camel production and disease, including extensive research activities.Professor David Shu-Cheong Hui, Stanley Ho Professor of Respiratory Medicine and Director, Stanley Ho Centre for Emerging Infectious Diseases, The Chinese University of Hong Kong, Hong Kong SAR, China
Professor Hui is the Stanley Ho Professor of Respiratory Medicine and Director, Stanley Ho Centre for Emerging Infectious Diseases, the Chinese University of Hong Kong.
Dr Hui was heavily involved in the clinical management of patients with Severe Acute Respiratory Syndrome (SARS) during the major outbreak in Hong Kong in 2003. He served as a WHO advisor to review the clinical management of influenza A(H5N1) during the early human outbreak in Vietnam in February 2004 and has since been a regular advisor to the WHO on the clinical management of severe acute respiratory infections.
Dr Hui has contributed to the WHO treatment guidelines (including the clinical management of influenza A (H5N1) virus in 2007, clinical management of influenza A (H1N1) pandemic in 2009, the Middle East Respiratory Syndrome (MERS) and the WHO training workshop in the clinical management of influenza A(H7N9)), in addition to joining several WHO missions on MERS in the Middle East and the Republic of Korea.Dr Marion Koopmans, Professor of Public Health Virology, Viroscience Department (head of department starting July 2014), Erasmus University of Rotterdam; and Chief, Virology Department, Laboratory for Infectious Diseases and Screening, National Institute of Public Health and the Environment, Kingdom of the Netherlands
Professor Marion Koopmans is a professor of public health virology in the Viroscience Department of the Erasmus University of Rotterdam. Starting in July 2014, Professor Koopmans will head this Department.
Previously, Professor Koopmans was Chief of Virology at the National Institute of Public health and the Environment in Bilthoven, Kingdom of the Netherlands.
Other current professional activities of Professor Koopmans include memberships in the National Organisation for Medical Microbiologists, the European Society for Virology and CReSA (Centre de Recerca en Sanitat Animal) in Barcelona, Spain. She is also an ad hoc expert advisor to the National Health Council and National Outbreak Management Teams (including on SARS, Marburg, avian influenza and MERS). a scientific advisor to the Guangdong Center of Disease Control and Prevention, Peoples Republic of China, and Editor of the Journal of Clinical Virology.Professor Malik Peiris, Director, School of Public Health and Chair in Virology; Co-Director, WHO H5 Reference Laboratory, The University of Hong Kong, Hong Kong SAR, China
Professor Peiris is a clinical and public health virologist with a particular interest in emerging virus disease at the animal-human interface including influenza, coronaviruses and others. His current research encompasses the pathogenesis, innate immune responses, transmission, ecology and epidemiology of human and animal (poultry, swine, wild birds) influenza viruses. His research has provided understanding on the emergence and pathogenesis of the 2009 pandemic H1N1 virus and on avian influenza viruses H5N1, H9N2 and H7N9. His collaborative research has provided evidence-based options for the control of these viruses in poultry and in humans. In 2003, he played a key role in the discovery that a novel coronavirus was the cause of Severe Acute Respiratory Syndrome (SARS), its diagnosis and pathogenesis. Currently he is researching Middle East Repiratory Syndrome coronavirus (MERS-CoV).
He co-directs the WHO H5 Reference Laboratory at The University of Hong Kong and serves on many standing committees and ad-hoc advisory committees of the WHO and Food and Agriculture Organization of the United Nations.Ms Karen Tan, Senior Director, Public Communication Division, Ministry of Communications and Information, Singapore
Ms Tan is Senior Director with the Public Communication Division of Ministry of Communications and Information in Singapore. Her current portfolio includes the strengthening of Whole-of-Government public communications, ensuring consistent messaging and building capacity in content development. Specifically, she is responsible for crisis communications for the government and leading Whole-of-Government efforts in the planning and execution of key public communications initiatives, which includes news media engagement, public engagement and national marketing for Singapore.
Prior to her current position, Ms Tan served at the Ministry of Health (Singapore) for 10 years. At the Ministry of Health, she had a dual capacity as the Director of Corporate Communications and as Press Secretary to the Minister for Health. During that time she was responsible for strategic communications planning, media relations, issue management, corporate publications, community relations and public consultations. She was responsible for all aspects of mass communications during the SARS epidemic in 2003 and the influenza A (H1N1) pandemic in 2009.
Ms Tan has served as a WHO Temporary Advisor on Outbreak Communications and IHR implementation, and was involved in various capacity building initiatives in risk communications.Dr Maria Van Kerkhove, Head, Outbreak Investigation Task Force, Center for Global Health, Institut Pasteur, Paris, France
Dr Van Kerkhove is also currently a technical consultant for WHO as a member of the Middle East respiratory syndrome coronavirus (MERS-CoV) task force. She has worked with WHO to routinely analyze available data from countries and conduct risk assessments, and regularly participated on Missions to affected countries.
Dr Van Kerkhove was previously employed by Imperial College London in the Medical Research Council Centre for Outbreak Analysis and Modelling where she worked closely with WHO on influenza, yellow fever, meningitis, MERS-CoV and Ebola Virus Disease.
feckit posted Apr 26, 2016 at 6:40 PM
Becky posted Apr 26, 2016 at 4:58 PM
WCG Stats posted Apr 26, 2016 at 8:00 AM
muckshifter posted Apr 25, 2016 at 7:06 PM
Becky posted Apr 25, 2016 at 3:20 PM
Becky posted Apr 25, 2016 at 3:09 PM
WCG Stats posted Apr 25, 2016 at 8:00 AM
V_R posted Apr 24, 2016 at 6:04 PM
WCG Stats posted Apr 24, 2016 at 8:00 AM
Guajiro posted Apr 23, 2016 at 4:39 PM
Officials Seeking More than 600 Passengers on Patient's Flight; Patient Feeling Well in Hospital
May 30, 2007 -- Health officials are reaching out to more than 600 people who flew on recent transatlantic flights with a man who has extensively drug-resistant tuberculosis (XDR TB).
XDR TB is an infectious disease spread from person to person through the air. Unlike most tuberculosis cases, XDR TB resists the first and secondpreferred drug treatments.
The man remains under a federal isolation order at an Atlanta hospital. He "continues to feel well" and shows no obvious signs of his tuberculosis, says Martin Cetron, MD, director of the CDC's Division of Global Migration and Quarantine.
The man's tuberculosis doesn't appear to be highly contagious, Cetron notes, but about 80 people on both flights may be at the highest risk since they were sitting in his row or in the two rows in front of or behind his seat.
Plans are under way to transport the man to Denver for treatment at the National Jewish Medical and Research Center. The CDC is helping with the logistics of those plans so as not to endanger other travelers, Cetron notes.Patient's Flights
The CDC today provided more information on the man's transatlantic flights.
On May 12, he flew from Atlanta to Paris on Air France flight 385. His exact seat on that flight isn't clear, but it may have been around row 51, Cetron notes. There were 433 passengers and 18 crew members on that flight. About 40-50 passengers were in the high-risk seats near the patient.
On May 24, the man flew from Prague in the Czech Republic to Montreal on Czech Air flight 0104 in seat 12C. There were 191 passengers and nine crew members on that flight. About 30 passengers were in the high-risk seats near the man.
So far, health authorities haven't reached passengers on those flights, but some have come forward after hearing about the situation. Passengers on those flights can call the CDC at (800) CDC-INFO for more information, says Cetron.
The man also took several other flights: from France to Greece; from Greece to Italy; and from Italy to Prague. But because those flights are shorter than eight hours, they aren't considered as risky for tuberculosis transmission by World Health Organization standards.Patient's Story
In an interview in today's Atlanta Journal-Constitution. the patient told a reporter that he and his wife left the U.S. for their honeymoon.
The man reportedly said he knew he had tuberculosis that hadn't responded to drug treatments but felt healthy. He says that local officials never told him not to travel but said they "preferred" he not travel.
The Atlanta Journal-Constitution says the man and his bride flew to Paris, then Athens, and then Rome. In Rome, he says the CDC called him and asked him to report for quarantine. Instead, he and his new wife left for Prague, flew to Montreal, and then drove into the U.S.
The man told The Atlanta Journal-Constitution that he "didn't want to put anybody at risk" but feared unsuccessful treatment in Italy.CDC's Story
In today's news conference, Cetron says it's the CDC's understanding that local health officials in Atlanta "clearly told him not to travel."
"The patient had, from his own perspective, compelling reasons to travel, and there were no legal orders in place preventing his travel and no laws were broken," Cetron says, noting that the CDC was looking into options to isolate the man in Rome but that opportunity was missed when the man and his wife left Italy.
Cetron says that when he learned the man and his wife had driven from Montreal into the U.S. he called the man on his cell phone with isolation instructions.
"Since we issued our federal isolation order, he has been fully compliant. I believe that aspect of the past is not nearly as important as. moving forward," Cetron says.
SOURCES: Martin Cetron, MD, director, Division of Global Migration and Quarantine, CDC. Ken Castro, MD, director, Division of Tuberculosis Elimination, CDC. WebMD Health News: "Fliers Warned About Tuberculosis." The Atlanta Journal-Constitution: "Atlantan Quarantined With Deadly TB Strain," May 30, 2007.
© 2007 WebMD Inc. All rights reserved.
July 1, 1999
Web posted at: 5:32 PM EDT (2132 GMT)
ATLANTA (Reuters) -- A flu outbreak has stricken at least 532 people in Alaska and Canada's Yukon Territory, most of them tourists on cruises to see the region's glaciers and other panoramic sights, U.S. health officials said Thursday.
The Centers for Disease Control and Prevention (CDC) said 428 tourists and 104 tourism workers developed acute respiratory infection with cough and fever between May 22 and June 28. The CDC had previously reported 388 cases through June 21.
The illnesses occurred among passengers on seven separate week-long cruises, the CDC said. Four tourists have been hospitalized, but there have been no deaths.
"This looks like Influenza A virus," said Dr. Martin Cetron, chief of surveillance epidemiology in the Division of Quarantine of the CDC's National Center for Infectious Diseases.
The CDC said that in many cases people became infected with influenza, a viral infection of the respiratory tract, during the land portion of their tours.
"Last year there was a similar outbreak of Influenza A infection among tourism workers and tourists in the Alaska tourist region over four months or more, and (it) was fairly widespread," Cetron said.
The CDC said about 40,000 tourists and tourism workers were affected by 1998's outbreak in Alaska and the Yukon Territory.
Cetron said "anyone age 65 or older or anyone with an underlying chronic health problem" should consult a doctor before going to the region.
"Talk to your doctor about the signs and symptoms of flu and the advisability of carrying antiviral medications with you should you develop symptoms," he said.
Copyright 1999 Reuters. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Note: Pages will open in a new browser window
Title: Cepeda: An Epidemic's Allies Reside In The Schoolhouse
Date: September 29, 2012
Source: Lubbock Online
Abstract : It’s been an alarming few days of obesity-related news. First, the Robert Wood Johnson Foundation released the results of its “F as in Fat” report, projecting half of U.S. adults will be obese by 2030 unless Americans make drastic dietary changes.
Then The New York Times reported, according to data published by the University of Illinois at Chicago, white people lacking a high school diploma are experiencing sharp drops in life expectancy, reversing generations of progress to extend life spans. There are many possible reasons, including higher rates of smoking and a spike in prescription overdoses, but the skyrocketing rate of obesity is a known suspect.
Tuesday marked the release of the most recent report from Mission: Readiness, an organization of about 300 retired generals, admirals and senior civilian military leaders who are trying to spread the word that obesity, and specifically childhood obesity, is a dire national security risk.
The report, called “Still Too Fat to Fight,” takes on cheap junk foods readily available in our schools. According to Mission: Readiness, students in the U.S. consume almost 400 billion calories from junk food sold at schools each year.
This will come as no surprise to anyone who has spent time in high schools — especially those in lower-income communities — where students routinely turn down their free or reduced-price breakfasts or lunches in favor of sacks of salty snacks and high-sugar beverages. And though grade-schoolers usually can’t get away with waiving their federal nutrition guideline-monitored meals, they often have a wide variety of cakes, cookies, candy and chips available to add to them — either in the cafeteria or from vending machines.
The report features some cringe-worthy statistics: One in four young adults is unable to serve in the military because of excess body fat, and even many of the ones who do manage to enlist are at high risk of injury. The military’s health insurance system, according to Mission: Readiness, spends “well over $1 billion a year on treating weight-related diseases such as diabetes and heart disease” in addition to the cost of musculoskeletal injuries resulting from inadequate physical fitness and low levels of bone density that may be related to the plunge in dairy intake and a corresponding rise in childhood consumption of sodas and sugary drinks over the past 35 years.
In the civilian population, studies recently named obesity the most expensive public health issue, costing the country more than $190 billion annually.
During a teleconference the American Beverage Association held last May, President and CEO Susan Neely told reporters that over the course of the last three years ABA’s voluntary efforts to curb sugar in schools has resulted in a 97 percent decline in full-calorie soft drinks in schools, and marketing of soft drinks to children under 12 decreased 96 percent since 2004.
She estimated a savings of approximately 1 trillion calories. In view of recent data establishing a strong causal link between limiting sugary drinks and a reduction in childhood obesity, this is a big step in the right direction.
So there is reason to be optimistic. We can reduce childhood obesity, we just have to keep pressure on the makers of all the goodies that entice our children when they’re out of our reach.
At least we’re not alone — if Uncle Sam says we’re all at risk when our kids have full access to junk at school, there’s a good chance more people will begin to demand that schools put a stop to it (Lubbock Online, 2012).
Title: Doctors Have Mixed Feelings On School Vaccinations
Date: October 3, 2012
Source: Fox News
Abstract : Colorado doctors mostly support local efforts to give kids their flu shots and other vaccines at school - but they also have misgivings, a new study shows.
In particular, they threw more support to school flu shots, versus other vaccinations. They were also worried about how school vaccinations would affect their record-keeping and their bottom line.
The study, reported in the journal Pediatrics, looked at doctors' feelings on so-called school-located vaccination - one-day "clinics" where local health officials and school districts offer kids flu shots or other vaccinations.
The programs are seen as a potential way to bring more kids up-to-date with government-recommended vaccinations.
Since 2010, the U.S. has advised nearly all Americans age six months and up to get an annual flu shot.
Even though only a minority follow that advice - about 43 percent of Americans did during the 2010 flu season - that still translates to more than 100 million people clambering for the flu vaccine within the space of a few months.
"To get all of those people into the doctor's office is impossible," said Dr. Judith Shlay of the Denver Public Health Department, the senior researcher on the new study.
In Denver, a project funded by the Centers for Disease Control and Prevention has provided in-school flu shots, as well as vaccinations recommended for older kids and teenagers: the meningococcal meningitis vaccine, the human papilloma virus (HPV) vaccine and the "Tdap" vaccine against tetanus, diphtheria and pertussis (whooping cough).
For the current study, Shlay's team wanted to know how pediatricians and family doctors felt about school vaccinations.
Of the 584 doctors who responded to the survey, most supported in-school flu shots.
About two-thirds were in favor of their privately insured patients getting the shot at school, while around three-quarters liked the idea for their patients on Medicaid.
A financial consideration likely factors in there, since the federal government provides free vaccines for kids on Medicaid, but doctors may have a tough time being reimbursed for the administration costs. Shlay's team found less support for kids getting other vaccinations at school. Half of pediatricians and 59 percent of family doctors were for it when it came to patients with private insurance; 59 percent and 67 percent, respectively, supported it for Medicaid patients.
One concern was that if older kids get all their vaccinations at school, they won't come in for routine check-ups. Many doctors were also worried they'd have a hard time keeping their patients' records straight.
"If we give vaccinations in schools and the doctor doesn't know about it, then that's a concern," Shlay said.
There is a way to address that, though. Colorado, and all other U.S. states, have computerized immunization registries that offer a consolidated record of children's vaccination histories.
"That's a really important tool," Shlay said.
But of the doctors in this survey, about one-third were not participating in Colorado's immunization registry.
If more providers get involved in state registry systems, that could help ease worries over record-keeping, Shlay's team writes.
Many doctors were also concerned about their bottom line. Most were at least somewhat worried that if an unpredictable number of patients got their vaccinations at school, their offices would have a tough time estimating how many vaccine doses to have in stock.
Shlay said that's a legitimate concern, since the vaccines for older kids and teens are expensive. (The retail price of the HPV vaccine, for example, is about $130 per dose.)
"If (doctors) end up with unused, expired vaccines, that's a problem," Shlay said. The potential waste, she added, is a concern not only for doctors, but for everyone who needs the vaccines.
So that may mean doctors' offices will need to be more careful in terms of inventory, Shlay noted.
But even if your child gets vaccinated at school, that's not a replacement for check-ups with the doctor.
"There's more to health and healthcare than just vaccines," Shlay noted.
It's important, she said, for doctors, public health officials and schools to all work together to make school vaccination programs effective - and, in the bigger picture, get all kids their appropriate vaccinations.
A government study last year found that that goal is fairly far off: Only 49 percent of U.S. teens had received the first of three doses of the HPV vaccine, while 63 percent had gotten the meningitis vaccine and 69 percent the Tdap shot.
"School-located vaccine programs are an important approach to augment vaccine delivery," Shlay said (Fox News, 2012).
Title: Should Schools Close During Bad Flu Outbreaks?
Date: October 30, 2012
Source: Fox News
Abstract : A new U.S. government study suggests that during a serious flu epidemic, closing schools can keep people - especially kids - out of the ER.
Now, researchers say, the big questions include, When is it best to close schools? And what are the downsides?
The study, reported in the journal Clinical Infectious Diseases, looked at what happened in two Texas communities during the H1N1 "swine" flu epidemic of 2009. In one community, schools were closed as a precaution; in the other, they weren't.
It turned out that in the district where schools shut down, there were fewer ER visits for the flu.
What's more, among kids age 6 and up, there was no increase in flu-related ER trips, while that rate doubled in the community where schools stayed open.
"The effect was most dramatic among school-age children," said Dr. Martin S. Cetron, of the Centers for Disease Control and Prevention (CDC).
There have been skeptics who've doubted that school closures could have much impact during a major flu outbreak, according to Cetron.
"They've said, well, people will just congregate in malls or other public places," explained Cetron, who directs the CDC's division of global migration and quarantine, and worked on the study.
But schools are different from malls, Cetron pointed out, with kids being in close contact with each other all day long.
He said he thinks this study, along with others, "settles" the question of whether school closures are effective. "Should this be an arrow in our quiver? I think the answer is ‘yes,'" Cetron said.
But lots of other questions remain.
"Under what conditions could (school closures) be warranted?" Cetron said. "What level of severity is needed?"
And if schools are closed, he noted, what are the downsides? Parents will have to stay home from work, or find child care. And kids and teachers will have to make up the lost school time somehow. So the expected benefits of school closings would need to be worth the troubles.
Prediction is Difficult
Every year, between five percent and 20 percent of Americans get the flu, contributing to some 36,000 deaths. The elderly and people with chronic medical conditions, like heart or lung disease, are among those most at risk.
But the 2009 H1N1 flu epidemic was noteworthy in that it hit children and healthy young adults hard.
The current study looked at two adjacent counties in Texas: Tarrant County, which closed its schools for eight days after a few kids were diagnosed with H1N1; and Dallas County, where schools did not shut down after a few cases were detected.
Before Tarrant County's school closures, the flu accounted for about 3 percent of all ER visits to area hospitals; during the closures, that rate inched up to just over 4 percent. But the increase was bigger in Dallas County during the same time period: from 3 percent, to just over 6 percent.
The impact was most clear among kids ages 6 to 18. In Tarrant County, there was no increase in the proportion of ER visits blamed on the flu. In Dallas County, the figure more than doubled, from about 5 percent to 11 percent.
"It's important to point out that this was a pre-emptive school closure," Cetron said. "Usually, most closures we see are reactive."
Predicting how a flu outbreak might affect a local area is far from easy. It's not like tracking a hurricane, for instance, Cetron pointed out.
Decisions on school closures are made locally. For school districts to make wise decisions, Cetron said communication with local and state health agencies is key (Fox News, 2012).
Title: Mumps Outbreak Traced To Face-To-Face Schooling, Study Suggests
Date: November 1, 2012
Source: Fox News
Abstract : A face-to-face educational method used among Orthodox Jews apparently led to a U.S. outbreak of mumps in 2009 and 2010 even though most of those infected had been properly vaccinated, according to a U.S. study.
The outbreak, detailed in the New England Journal of Medicine, indicates how close, repeated contact with an infected person can overwhelm the mumps vaccine, the researchers said.
"The risk of infection with mumps may be higher when the exposure dose of virus is large or intensely transmitted," wrote lead author Albert Barskey, of the U.S. Centers for Disease Control and Prevention's (CDC) National Center for Immunization and Respirators Diseases, and colleagues.
This may also explain why the mumps vaccine tends to be less effective among household contacts than among school or community contacts, they added.
In the mumps outbreak, 3,502 cases were reported over a one-year period beginning in June 2009 in New Jersey, New York City and New York State's Orange and Rockland counties. A camp in the Catskill Mountains was the source.
The researchers, from the involved state health departments and the CDC, studied 1,648 of those cases, nearly all of them Orthodox Jews. The researchers found that 89 percent had received the recommended two doses of mumps vaccine.
Many attended a religious school known as a yeshiva, where boys receive intense training with a study partner known as a chavrusa, who sits across a narrow table. The teaching method often involves animated discussions and the partners are switched several times a day.
The researchers wrote that "chavrusa study, with its prolonged, face-to-face contact," probably resulted in high exposures to the virus, and these "overcame vaccine-induced protection in individual students."
The large families in Orthodox Jewish communities also contributed to the spread, Barskey told Reuters Health in a telephone interview.
"As the outbreak went on, we started to see younger and older cases, and females as well. What that suggests is there was spread in the households. From family it would jump to a new school," he said.
"The chavrusas played the biggest role. The households played a lesser role."
The source of the outbreak was eventually traced to an 11-year-old boy, who had himself received two vaccine doses but nonetheless picked up the disease in the United Kingdom, where fears about vaccination had led to a large mumps outbreak.
That child attended the camp, which had about 400 Orthodox Jewish boys (Fox News, 2012).
Title: Virus Breaks Out At NYC School Being Used As Storm Shelter
Date: November 6, 2012
Source: NBC New York
Abstract : A Brooklyn high school being used as a shelter for Sandy victims has to be shut down and sanitized after about a dozen storm refugees came down with a stomach virus.
Mayor Bloomberg said John Jay High School will be closed Wednesday instead of opening for classes as scheduled.
"The school will be thoroughly cleaned and then reopened," Bloomberg said.
The mayor said none of the sickened storm victims was severely ill. The cleaning is being done as a precaution, he said.
Thousands of city residents from low-lying areas stayed in shelters as Sandy smashed the tri-state.
Bloomberg also said 10 schools that suffered storm damage or lost power will open Wednesday. The majority of city schools reopened on Monday.
Another 47 schools still won't be open Wednesday. Bloomberg said parents should check www.nyc.gov to see where those students will need to report (NBC New York, 2012) .